280 related articles for article (PubMed ID: 23234256)
41. Insights into the mechanics of solid conical microneedle array insertion into skin using the finite element method.
Shu W; Heimark H; Bertollo N; Tobin DJ; O'Cearbhaill ED; Annaidh AN
Acta Biomater; 2021 Nov; 135():403-413. PubMed ID: 34492370
[TBL] [Abstract][Full Text] [Related]
42. Transdermal Microneedles-A Materials Perspective.
Ali R; Mehta P; Arshad MS; Kucuk I; Chang MW; Ahmad Z
AAPS PharmSciTech; 2019 Dec; 21(1):12. PubMed ID: 31807980
[TBL] [Abstract][Full Text] [Related]
43. [Design and manufacture of microneedles array for transdermal drug delivery].
Zhang JY; Zhao YJ; Yang XL
Zhongguo Yi Liao Qi Xie Za Zhi; 2006 Jan; 30(1):33-8. PubMed ID: 16646423
[TBL] [Abstract][Full Text] [Related]
44. An array of porous microneedles for transdermal monitoring of intercellular swelling.
Nagamine K; Kubota J; Kai H; Ono Y; Nishizawa M
Biomed Microdevices; 2017 Sep; 19(3):68. PubMed ID: 28776235
[TBL] [Abstract][Full Text] [Related]
45. Metallic microneedles with interconnected porosity: A scalable platform for biosensing and drug delivery.
Cahill EM; Keaveney S; Stuettgen V; Eberts P; Ramos-Luna P; Zhang N; Dangol M; O'Cearbhaill ED
Acta Biomater; 2018 Oct; 80():401-411. PubMed ID: 30201432
[TBL] [Abstract][Full Text] [Related]
46. Trilayer microneedle array assisted transdermal and intradermal delivery of dexamethasone.
Li M; Vora LK; Peng K; Donnelly RF
Int J Pharm; 2022 Jan; 612():121295. PubMed ID: 34785356
[TBL] [Abstract][Full Text] [Related]
47. Microneedle delivery: clinical studies and emerging medical applications.
Pettis RJ; Harvey AJ
Ther Deliv; 2012 Mar; 3(3):357-71. PubMed ID: 22833995
[TBL] [Abstract][Full Text] [Related]
48. Hydrogel-forming microneedle arrays as a therapeutic option for transdermal esketamine delivery.
Courtenay AJ; McAlister E; McCrudden MTC; Vora L; Steiner L; Levin G; Levy-Nissenbaum E; Shterman N; Kearney MC; McCarthy HO; Donnelly RF
J Control Release; 2020 Jun; 322():177-186. PubMed ID: 32200001
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of a minimally invasive glucose biosensor for continuous tissue monitoring.
Sharma S; Huang Z; Rogers M; Boutelle M; Cass AE
Anal Bioanal Chem; 2016 Nov; 408(29):8427-8435. PubMed ID: 27744480
[TBL] [Abstract][Full Text] [Related]
50. Microneedles for transdermal drug delivery.
Prausnitz MR
Adv Drug Deliv Rev; 2004 Mar; 56(5):581-7. PubMed ID: 15019747
[TBL] [Abstract][Full Text] [Related]
51. Successful application of large microneedle patches by human volunteers.
Ripolin A; Quinn J; Larrañeta E; Vicente-Perez EM; Barry J; Donnelly RF
Int J Pharm; 2017 Apr; 521(1-2):92-101. PubMed ID: 28216463
[TBL] [Abstract][Full Text] [Related]
52. Rapid fabrication method of a microneedle mold with controllable needle height and width.
Lin YH; Lee IC; Hsu WC; Hsu CH; Chang KP; Gao SS
Biomed Microdevices; 2016 Oct; 18(5):85. PubMed ID: 27565822
[TBL] [Abstract][Full Text] [Related]
53. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin.
Liu S; Jin MN; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
Eur J Pharm Biopharm; 2014 Feb; 86(2):267-76. PubMed ID: 24120887
[TBL] [Abstract][Full Text] [Related]
54. Microneedle mediated delivery of nanoparticles into human skin.
Coulman SA; Anstey A; Gateley C; Morrissey A; McLoughlin P; Allender C; Birchall JC
Int J Pharm; 2009 Jan; 366(1-2):190-200. PubMed ID: 18812218
[TBL] [Abstract][Full Text] [Related]
55. Microneedle Mediated Transdermal Delivery of Protein, Peptide and Antibody Based Therapeutics: Current Status and Future Considerations.
Kirkby M; Hutton ARJ; Donnelly RF
Pharm Res; 2020 Jun; 37(6):117. PubMed ID: 32488611
[TBL] [Abstract][Full Text] [Related]
56. Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety.
Donnelly RF; Raj Singh TR; Woolfson AD
Drug Deliv; 2010 May; 17(4):187-207. PubMed ID: 20297904
[TBL] [Abstract][Full Text] [Related]
57. An overview on the advantages and limitations of 3D printing of microneedles.
Ozyilmaz ED; Turan A; Comoglu T
Pharm Dev Technol; 2021 Nov; 26(9):923-933. PubMed ID: 34369288
[TBL] [Abstract][Full Text] [Related]
58. Review of patents for microneedle application devices allowing fluid injections through the skin.
Lhernould MS; Tailler S; Deleers M; Delchambre A
Recent Pat Drug Deliv Formul; 2015; 9(2):146-57. PubMed ID: 25770583
[TBL] [Abstract][Full Text] [Related]
59. Patient safety and beyond: what should we expect from microneedle arrays in the transdermal delivery arena?
Donnelly RF; Woolfson AD
Ther Deliv; 2014 Jun; 5(6):653-62. PubMed ID: 25090279
[TBL] [Abstract][Full Text] [Related]
60. Effect of microneedle geometry and supporting substrate on microneedle array penetration into skin.
Kochhar JS; Quek TC; Soon WJ; Choi J; Zou S; Kang L
J Pharm Sci; 2013 Nov; 102(11):4100-8. PubMed ID: 24027112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
